Properties
What is it?
International Nonproprietary Name - Propolis, Vaccinium macrocarpon, Ortosiphon Composition: 1 tablet contains: Propolis - 100 mg Cranberry (Vaccinium macrocarpon) - 100 mg Orthosiphon (Ortosiphon stamineus) - 100 mg Uva Ursi (Arctostaphylos uva-ursi) - 100 mg Corn Silk (poaceae zea mays I.) - 100 mg Magnesium Citrate - 100 mg Horsetail (Equisetum arvense) - 50 mg Dandelion (Taraxacum officinale) - 50 mg Bilberry (Vaccinium myrtillus) - 50 mg Pharmacological group: Uroseptic, anti-inflammatory, antispasmodic, diuretic, choleretic agent. Indications: Urinary tract infections: cystitis, urethritis; pyelonephritis; vaginitis, vulvitis; treatment (in complex therapy) and prevention of urolithiasis; in case of high formation of salts (urates, oxalates, phosphates, carbonates) in the urinary system; gout; nephrotic syndrome; arterial hypertension, heart failure; cholecystitis; ascites; helminthic invasions. Contraindications: Hypersensitivity to the components of the preparation. Use during pregnancy and lactation: Nefrovis can be used during the II and III trimesters of pregnancy and during lactation. Dosage and administration: 1-2 tablets 2 times a day, in the morning and evening after meals. The duration of treatment is 2-8 weeks. Interaction with other drugs: Not identified. Dosage form: Tablet N 30, in a cardboard box with an insert leaflet. Storage conditions: Store in a dry place, protected from sunlight, inaccessible to children, at a temperature not exceeding 250C. Shelf life: Indicated on the packaging, do not use after the expiry date. Dispensing condition: Over-the-counter (food supplement). Product and trademark owner company: “WISE PHARMA” S.R.L, United Kingdom.